These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17591568)

  • 1. Radiotherapy of hodgkin lymphoma: indications, new fields, and techniques.
    Girinsky T; Ghalibafian M
    Semin Radiat Oncol; 2007 Jul; 17(3):206-22. PubMed ID: 17591568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
    Hodgson DC; Hudson MM; Constine LS
    Semin Radiat Oncol; 2007 Jul; 17(3):230-42. PubMed ID: 17591570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contemporary use of radiation therapy in the management of lymphoma.
    Boyle T; McPadden E
    Surg Oncol Clin N Am; 2000 Jul; 9(3):621-37, xi. PubMed ID: 10853146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involved field radiotherapy for limited stage Hodgkin lymphoma: balancing treatment efficacy against long-term toxicities.
    Goda JS; Tsang RW
    Hematol Oncol; 2009 Sep; 27(3):115-22. PubMed ID: 19274613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?
    Ghalibafian M; Beaudre A; Girinsky T
    Radiother Oncol; 2008 Apr; 87(1):82-8. PubMed ID: 18037182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT).
    Yahalom J
    Eur J Haematol Suppl; 2005 Jul; (66):90-7. PubMed ID: 16007875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies for the treatment of early stages of Hodgkin's lymphoma.
    Macdonald DA; Connors JM
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):871-80. PubMed ID: 17908625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality treatment of Hodgkin's lymphoma.
    Klimm B; Engert A
    Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hodgkin lymphoma: evolution and dilemma in radiation treatments].
    Girinsky T; Ghalibafian M; Paumier A
    Cancer Radiother; 2009 Oct; 13(6-7):479-81. PubMed ID: 19656714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Kuleva SA
    Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.
    Lu H; Peng L; Yuan X; Hao Y; Lu Z; Chen J; Cheng J; Deng S; Gu J; Pang Q; Qin J
    Cancer Treat Rev; 2009 Jun; 35(4):345-53. PubMed ID: 19211192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of radiation therapy in Hodgkin's lymphoma.
    Yahalom J
    Cancer J; 2009; 15(2):155-60. PubMed ID: 19390312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern radiotherapeutic strategies in the management of lymphoma.
    Ballas L
    Future Oncol; 2015; 11(6):1011-20. PubMed ID: 25760980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
    Eich HT; Müller RP
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?
    Longo DL
    J Natl Cancer Inst; 2005 Oct; 97(19):1394-5. PubMed ID: 16204683
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective.
    Lister TA
    J Clin Oncol; 2008 Nov; 26(32):5144-6. PubMed ID: 18854554
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.